Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 96.0 | 51 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 89.0 | 46 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 97.0 | 51 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 91.0 | 35 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 86.5 | 62 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 86.0 | 30 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 84.0 | 39 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 84.0 | 41 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 92.0 | 43 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | TNFb | 79.0 | 44 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 37.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 36.5 | 46 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 42.5 | 46 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 51.0 | 55 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 39.5 | 52 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 45.0 | 41 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 39.0 | 50 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 43.0 | 47 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 47.0 | 43 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 36.0 | 37 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 35.0 | 41 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | TNFb | 48.0 | 32 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | TNFb | 38.0 | 51 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | TNFb | 36.5 | 60 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | TNFb | 35.0 | 47 |